retatrutide clinical data Retatrutide heart rate: what the clinical data actually shows First phase 3 data for
Description
We're talking about a revolutionary class of medications called GLP-1 (glucagon-like peptide-1) receptor agonists
GLP-1 activity support Can promote satiety and help reduce appetite
Blue skies and tailwinds!
Across trials, 30% to 80% of patients achieve hemoglobin A1c targets below 7%, with semaglutide often producing the greatest reductions
